NRC Health (NRC) Q4 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Nrc Health.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.089 -- 00:00:03.831 will be in a listen-only mode. There will be a Q&A. 00:00:03.831 -- 00:00:08.313 To register a question, please press Start, followed by 1 on your telephone keypad. 00:00:08.313 -- 00:00:11.674 If you change your mind, please press Start, followed by 2. 00:00:11.674 -- 00:00:16.056 At this time, I would like to turn the conference over to Kevin Karras, Chief Financial 00:00:16.056 -- 00:00:17.697 Officer. Please go ahead when you are ready. 00:00:17.697 -- 00:00:19.697 Thank 00:00:19.818 -- 00:00:25.381 you, Drew. And welcome, everyone, to today's National Research Corporation 00:00:25.381 -- 00:00:30.497 earnings call. Joining me on the call today is Linda Stacey, our Vice President of 00:00:30.497 -- 00:00:31.979 Finance. 00:00:31.979 -- 00:00:36.643 Before we continue, I would like to ask Linda to review conditions related to any forward-looking 00:00:36.643 -- 00:00:40.046 statements that may be made as part of today's call. 00:00:40.046 -- 00:00:40.967 Linda? 00:00:40.967 -- 00:00:45.231 Thank you, Kevin. This conference call includes forward-looking statements related to 00:00:45.231 -- 00:00:50.335 the company that involve risks and uncertainties that could cause actual results 00:00:50.335 -- 00:00:54.332 or outcomes to differ materially from those currently anticipated. 00:00:54.332 -- 00:00:58.774 These forward-looking statements are made pursuant to the safe harbor provisions of the 00:00:58.774 -- 00:01:01.856 Private Securities Litigation Reform Act of 1995. 00:01:01.856 -- 00:01:06.758 For further information about the facts that could affect the company's future results, 00:01:06.758 -- 00:01:10.279 please see the company's filings with the Security and Exchange Commission. 00:01:10.279 -- 00:01:11.700 With that, I'l...